FDA lifts hold on Biomea’s diabetes trials

The FDA lift­ed a clin­i­cal hold on two tri­als test­ing Bio­mea Fu­sion’s di­a­betes treat­ment.

The news, an­nounced Thurs­day, sent the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.